Clinical Trial Update: Safety and Efficacy of Reduced Versus Standard Dose Efavirenz (EFV) Plus Two Nucleotides in Antiretroviral-naïve Adults. [Phase 3]

View source ↗

Summary

Phase 3 trial comparing reduced-dose versus standard-dose efavirenz with two NRTIs in antiretroviral-naïve adults; completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infections

Drugs mentioned

• EFAVIRENZ (efavirenz)

Snippet

Sponsor: Kirby Institute | Conditions: HIV Infections | Phase 3 | Status: COMPLETED | Results posted: 2020-02-21